BE1001630A4 - Adjuvants immunologiques pour vaccins polysaccharidiques. - Google Patents

Adjuvants immunologiques pour vaccins polysaccharidiques. Download PDF

Info

Publication number
BE1001630A4
BE1001630A4 BE8700410A BE8700410A BE1001630A4 BE 1001630 A4 BE1001630 A4 BE 1001630A4 BE 8700410 A BE8700410 A BE 8700410A BE 8700410 A BE8700410 A BE 8700410A BE 1001630 A4 BE1001630 A4 BE 1001630A4
Authority
BE
Belgium
Prior art keywords
oil
sep
weight
biodegradable
emulsion system
Prior art date
Application number
BE8700410A
Other languages
English (en)
French (fr)
Inventor
John L Cantrell
Jon Rudbach
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Application granted granted Critical
Publication of BE1001630A4 publication Critical patent/BE1001630A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE8700410A 1986-04-15 1987-04-15 Adjuvants immunologiques pour vaccins polysaccharidiques. BE1001630A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/852,118 US4803070A (en) 1986-04-15 1986-04-15 Immunological emulsion adjuvants for polysaccharide vaccines

Publications (1)

Publication Number Publication Date
BE1001630A4 true BE1001630A4 (fr) 1989-12-27

Family

ID=25312539

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8700410A BE1001630A4 (fr) 1986-04-15 1987-04-15 Adjuvants immunologiques pour vaccins polysaccharidiques.

Country Status (9)

Country Link
US (1) US4803070A (enExample)
JP (1) JP2648305B2 (enExample)
BE (1) BE1001630A4 (enExample)
CA (1) CA1322333C (enExample)
CH (1) CH675076A5 (enExample)
DE (1) DE3712768A1 (enExample)
GB (1) GB2189143B (enExample)
IT (1) IT1205820B (enExample)
NL (1) NL194603C (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
EP0324455A3 (en) * 1988-01-15 1991-03-27 Hans O. Ribi Novel polymeric immunological adjuvants
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
FR2649013B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
DE4007315A1 (de) * 1990-03-08 1991-09-12 Behringwerke Ag Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5246707A (en) * 1990-04-26 1993-09-21 Haynes Duncan H Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
CA2106474C (en) 1991-03-19 2004-02-10 R. Martin Emanuele Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
JPH06507172A (ja) * 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド 転換可能なミクロエマルジョン処方剤
US5462735A (en) * 1993-06-10 1995-10-31 The United States Of America As Represented By The Secretary Of Agriculture Pasteurella haemolytica subunit vaccine containing capsular polysaccharide and muramyl dipeptide
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
CN1120809A (zh) 1993-12-23 1996-04-17 Gff工业方向促进研究公司 增强免疫应答的方法
US20070231402A1 (en) 1994-08-02 2007-10-04 Immunopath Profile, Inc. Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
KR100508910B1 (ko) 1995-10-17 2006-04-20 알티피 파마 코포레이션 불용성약물방출
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
CN1289091C (zh) * 1998-02-11 2006-12-13 Rtp药品公司 治疗炎症的药物组合物和相关用途
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
KR100635456B1 (ko) 1998-05-29 2006-10-18 스키에파마 캐나다 인코포레이티드 열보호화 마이크로입자 조성물 및 그의 말단의 스팀멸균방법
EP1105096B1 (en) 1998-08-19 2003-10-29 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
KR20010073232A (ko) * 1998-11-20 2001-07-31 추후제출 분산성 인지질로 안정화된 마이크로입자
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
JP2002537102A (ja) 1999-02-26 2002-11-05 カイロン コーポレイション 吸着された高分子および微粒子を有するミクロエマルジョン
JP2003509453A (ja) * 1999-09-21 2003-03-11 アールティーピー・ファーマ・インコーポレーテッド 生物学的に活性な物質の、表面改質された粒状組成物
HK1053786A1 (zh) 2000-04-20 2003-11-07 Rtp Pharma Inc. 改进的水不溶的药物颗粒工艺
ES2325057T3 (es) 2000-08-31 2009-08-25 Jagotec Ag Particulas molturadas.
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
JP2004509146A (ja) * 2000-09-20 2004-03-25 スカイファーマ・カナダ・インコーポレーテッド 安定化フィブレート微粒子
GB0031430D0 (en) 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides
PL202778B1 (pl) * 2001-02-22 2009-07-31 Skyepharma Canada Inc Postać dawkowana kombinacji statyny i fenofibratu, sposób jej wytwarzania i zastosowanie
SI1613346T1 (sl) * 2003-04-04 2013-02-28 Pah Usa 15 Llc Mikrofluidizirane emulzije olja v vodi in sestava cepiv
FR2873386B1 (fr) 2004-07-22 2011-01-14 Agence Francaise De Securite Sanitaire Des Aliments Afssa Composition vaccinale contre le rhodococcus equi
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
CA2623197A1 (en) * 2005-09-22 2007-03-29 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
AU2008303023B2 (en) 2007-09-27 2014-01-09 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
ES2383231T3 (es) * 2007-10-19 2012-06-19 Novartis Ag Formulaciones para vacunas meningocócicas
US20110070298A1 (en) 2008-06-05 2011-03-24 Immunovaccine Technologies Inc. Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
US10105435B2 (en) 2011-10-06 2018-10-23 Immunovaccine Technologies Inc. Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
WO2014055825A1 (en) * 2012-10-04 2014-04-10 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services A formulation of mycobacterial components as an adjuvant for inducing th17 responses
WO2019036663A1 (en) * 2017-08-17 2019-02-21 University Of Delaware FURANE COMPOSITIONS AND METHODS OF MAKING THE SAME
EP3774829A2 (en) 2018-04-13 2021-02-17 GlaxoSmithKline Biologicals S.A. Immunigenic alpha-branched trehalose-diesters

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527443A1 (fr) * 1982-05-26 1983-12-02 Ribi Immunochem Research Inc Composition contenant de l'endotoxine raffinee et medicament la contenant
FR2550945A1 (fr) * 1983-08-26 1985-03-01 Ribi Immunochem Research Inc Compositions d'endotoxines purifiees et leur application pharmacologique
GB2189141A (en) * 1986-04-15 1987-10-21 Ribi Immunochem Research Inc Immunological adjuvant

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2160326B1 (enExample) * 1971-11-19 1975-02-07 Anvar
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
GB1506563A (en) * 1974-04-25 1978-04-05 Williams J Immunosuppressive agents
US4338334A (en) * 1977-12-29 1982-07-06 Merck & Co., Inc. 1-[4-(4-Sulfanilyl)phenyl] urea and derivatives in compositions and methods of treating rheumatoid arthritis and immune complex diseases
ES483541A1 (es) * 1979-08-21 1980-03-01 Benlloch Llorach Alfredo Perfeccionamientos en los colectores de aparatos captadores de la energia solar.
US4307229A (en) * 1979-11-07 1981-12-22 Avraham Liav 6,6'-Diesters of trehalose and process for the synthesis thereof
US4340588A (en) 1980-03-28 1982-07-20 Research Corporation Brucellosis vaccine for cattle containing mycolate esters of trehalose
US4505900A (en) * 1982-05-26 1985-03-19 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
JPS6292947A (ja) * 1985-10-19 1987-04-28 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料の処理方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527443A1 (fr) * 1982-05-26 1983-12-02 Ribi Immunochem Research Inc Composition contenant de l'endotoxine raffinee et medicament la contenant
FR2550945A1 (fr) * 1983-08-26 1985-03-01 Ribi Immunochem Research Inc Compositions d'endotoxines purifiees et leur application pharmacologique
GB2189141A (en) * 1986-04-15 1987-10-21 Ribi Immunochem Research Inc Immunological adjuvant

Also Published As

Publication number Publication date
IT1205820B (it) 1989-03-31
JP2648305B2 (ja) 1997-08-27
IT8747856A0 (it) 1987-04-15
DE3712768A1 (de) 1987-10-22
DE3712768C2 (enExample) 1992-01-16
CA1322333C (en) 1993-09-21
NL194603B (nl) 2002-05-01
JPS6322029A (ja) 1988-01-29
US4803070A (en) 1989-02-07
NL8700892A (nl) 1987-11-02
GB8709124D0 (en) 1987-05-20
NL194603C (nl) 2002-09-03
GB2189143A (en) 1987-10-21
CH675076A5 (enExample) 1990-08-31
GB2189143B (en) 1990-07-25

Similar Documents

Publication Publication Date Title
BE1001630A4 (fr) Adjuvants immunologiques pour vaccins polysaccharidiques.
FR2598622A1 (fr) Adjuvants immunologiques pour vaccins polysaccharidiques
BE1001634A4 (fr) Vaccin contenant des antigenes de tumeurs et des adjuvants.
Rajananthanan et al. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses
JP3814290B2 (ja) 抗原用のアジュバントおよびその製法ならびに用途
White et al. The influence of components of M. tuberculosis and other mycobacteria upon antibody production to ovalbumin
JPH07509733A (ja) 代謝可能な油を含む油中水型のワクチン用液体エマルジョン
FR2472386A1 (enExample)
AU780054B2 (en) Oil adjuvant vaccine
JP2012025774A (ja) 多成分髄膜炎菌ワクチン
JP2004512384A (ja) 増強した免疫応答を有するワクチン、およびその調製方法
Lindblad Freund's adjuvants
JPH05507498A (ja) 改良されたアジュバントおよびワクチン
DE69534382T2 (de) Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind
FR2547500A1 (fr) Preparation pharmaceutique pour ulcere du tube digestif
FR2479000A1 (fr) Vaccin contre la brucellose, maladie du betail
FR2529462A1 (fr) Composition pharmaceutique comprenant un extrait de micro-organisme soluble dans la pyridine, un dimycolate de trehalose et un derive de glycolipides endotoxiques
WO1999016468A1 (fr) Vecteurs d'antigenes sous forme de vesicules multilamellaires
FR2536280A1 (fr) Composition pharmaceutique et procede pour le traitement de tumeurs
FR2462166A1 (fr) Compositions antigeniques, leur preparation et vaccins a base de ces compositions
ELFIKY et al. Improvement of snake antisera production using new innovative adjuvants (W/O FORMULATION)
RU2356538C1 (ru) Способ получения антигенсодержащих липосом
FR2692148A1 (fr) Composition adjuvante de l'immunité humorale et à médiation cellulaire n'induisant pas de réponse vis-à-vis de déterminants auto-antigéniques.
FR2692149A1 (fr) Composition adjuvante de l'immunité humorale et à médiation cellulaire n'induisant pas de réponse vis-à-vis de déterminants auto-antigéniques.
US20050266028A1 (en) Compositions and methods for modulating an immune response

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *RIBI IMMUNOCHEM RESEARCH INC.

Effective date: 20070415